Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening – Webinar Presentation – Video

Posted: Published on December 15th, 2011

This post was added by Dr P. Richardson



Human tissue cells derived from induced pluripotent stem (iPS) cells recapitulate many of the characteristics and functionality expected of in vivo cell types. iCell® Cardiomyocytes are derived from human IPS cells and are currently being used in both drug discovery and basic research in Industrial and Academic settings. Dr.

Excerpt from:
Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening - Webinar Presentation - Video

Related Posts
This entry was posted in Cell Medicine. Bookmark the permalink.

Comments are closed.